Drishti Offset: One Stop Shop For High Quality Printing Needs

Ashok Gupta, Chairman, Sandarbh Gupta & Anil Gupta, Directors

Ashok Gupta, Chairman

Sandarbh Gupta & Anil Gupta, Directors

In pharmaceutical packaging, where a single misprint can carry implications far beyond aesthetics, agility must nev­er come at the cost of accuracy. For many pharmaceutical organizations, choosing between a partner who delivers on time and one who satisfies the industry’s rigorous compli­ance and quality standards remains a constant trade-off. On the other hand, the printing and packaging providers need to navigate the complexity of batch-size variability, customiza­tion demands, and growing sustainability expectations. Mas­tering the balance of accuracy, customization, and sustain­ability in pharma packaging has become the core strength of Drishti Offset & Packaging Pvt Ltd.

Drishti Offset is a printing and packaging solutions provider that combines agility with compliance. Operating under the larger Drishti Group umbrella that operates in wide range of industries ranging from printing and packaging, real estate, cinemas, hotels and mining, the company brings end-to-end in-house capabilities across mono cartons, labels, flexible pouches, and marketing materials, ensuring quick turnarounds without cutting corners. Every output is a result of coordinated systems with compliance embedded into every layer of the operations. “My father Ashok Gupta and uncle Anil Gupta started the company in 1993 with quality, honesty and commitment as the company’s motto”, says Sandarbh Gupta, Director, Drishti Offset. “This is the base for everything that we do in this company and the entire group”, Sandarbh adds.

Packaging as Sales, and as Safeguard

At Drishti Offset, the role of packaging is treated with dual seriousness. First, it is seen as the ‘last salesman’ on a shelf, conveying brand values when the product itself cannot speak. Second, it functions as a security layer against tampering, counterfeiting, and shelf degradation. To deliver these, the design process at the company begins in collaboration with the client. It educates brand teams on functional design enhancements while offering technical options such as invisible inks, QR codes, holograms, and tamper-evident features, ensuring these protective elements integrate with the client’s visual identity.

with over three decades of experience, the company has grown from a modest single-color press into a full-fledged printing and packaging solutions provider

Ashok Gupta, Chairman, Sandarbh Gupta & Anil Gupta, Directors

Through vertical integration and robust in-house infrastructure, ranging from Heidelberg and Komori printing lines to automated die punching and pasting, Drishti Offset manages to accelerate production timelines while retaining documentation integrity and product validation. The company operates with defined SOPs at each operational checkpoint. From raw material procurement to dispatch, all stages are documented, barcoded, and audited. Random sampling and dual-operator quality checks ensure that risk is mitigated before scale-up. At every station, printed checklists of historically observed errors serve as live references, turning past mistakes into institutional knowledge. Furthermore, the company’s setup supports both high-volume and short-run production, making it adept at handling everything from 20 lakh-piece batches to 20-piece samples for product trials.

For all the emphasis on machines and compliance, Sandarbh repeatedly returns to his team as the cornerstone of reliability. Many employees have been with Drishti Offset for over 25 years. Staff are not just operators, they are guardians of process discipline. They are trained to understand the ‘why’ behind every packaging requirement, which gives them clarity in their work. This human capital investment is one of the reasons the company maintains near-zero defect rates, even at scale.

Redefining Customization & Sustainability

As product lines proliferate and drug formats diversify, pharmaceutical brands increasingly demand packaging solutions that are flexible in both scale and form. The company’s broad range of offerings enables it to serve a wide spectrum of client needs under one roof, significantly reducing coordination friction for brand teams managing diverse SKUs. Furthermore, Drishti Offset emphasizes genuine reductions in waste and energy consumption rather than greenwashed claims of 100 percent recyclability, which remain impractical at industrial scale. By investing in direct CTP-to-press integration, the company effectively eliminates make-ready wastage.

By replacing ACs with industrial coolers in non-critical zones, it minimizes power consumption, digitizes documentation to cut down on paper, and consistently invests in tree plantation around its facilities. Experimentation is also ongoing in alternative coatings to reduce dependence on lamination. The company is actively testing barrier-based varnishes and surface treatments that aim to retain functionality while easing environmental load.

Expanding Horizons

With over three decades of experience, the company has grown from a modest single-color press into a full-fledged printing and packaging solutions provider. With a legacy of excellence and scale, Drishti Offset serves a broad spectrum of industries, including pharmaceuticals, FMCG, IT, telecom, real estate, and public sector enterprises, with end-to-end print and packaging solutions. Beyond basic printing, the company delivers high-volume, high-precision outputs across mono cartons, flexible pouches, labels, brochures, and a wide range of promotional and corporate print collateral. From pharma-grade mono cartons to high-impact flexible packaging, Drishti Offset delivers precision, compliance, and innovation, trusted by industry leaders across sectors.

Drishti Offset currently serves a diverse clientele across India, including reputed pharmaceutical hubs and special economic zones, backed by GMP-aligned protocols and streamlined pan-India logistics. The company has built a reputation for precision, speed, and unwavering compliance. It has taken its first confident step onto the global stage, with export orders for Nepal and actively plans to expand into multiple international markets within the year.

Over the next five years, Sandarbh envisions Drishti Offset emerging as a globally trusted packaging partner-delivering world-class quality from its strategic base in Bhopal, while preserving the agility, values, and precision across the border. With rising demand for customized, compliant, and visually appealing packaging, the company is scaling efficiently and is fully equipped to deliver high volumes and complex designs without compromising quality.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.